
|Articles|April 5, 2011
ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin
Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
3
Screening Delays, Overlooked Symptoms Worsen CRC Outcomes in Younger Adults: Jordan Karlitz, MD
4
Bringing Academic Oncology Best Practices to Community Care: Anasuya Gunturi, MD, PhD
5
















